Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Response: priming of human naive CD4 + T cells via CD5 costimulation requires IL-6 for optimal Th17 development

Yuri Souwer, Jelle de Wit, Femke J. M. Muller, Hanny Klaasse Bos, Tineke Jorritsma, Martien L. Kapsenberg, Esther C. de Jong, S. Marieke van Ham

Blood (2012) 119 (20): 4812–4813.

https://doi.org/10.1182/blood-2012-03-415208

Published: 2012

Journal Articles

CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation

Jelle de Wit, Yuri Souwer, Astrid J. van Beelen, Rosa de Groot, Femke J. M. Muller, Hanny Klaasse Bos, Tineke Jorritsma, Martien L. Kapsenberg, Esther C. de Jong, S. Marieke van Ham

Blood (2011) 118 (23): 6107–6114.

https://doi.org/10.1182/blood-2011-05-352682

Published: 2011

Includes: Supplemental data

Journal Articles

Low CLIP Expression On Leukemic Blasts From AML Patients Is Essential for the Generation of Effective CD4 + T Cell Responses.

Marvin M. van Luijn, Martine E.D. Chamuleau, MD, PhD, James A. Thompson, Suzanne Ostrand-Rosenberg, PhD, Theresia M. Westers, PhD, Yuri Souwer, Gert J. Ossenkoppele, MD, PhD, S. Marieke van Ham, PhD, Arjan A. van de Loosdrecht, MD, PhD

Blood (2009) 114 (22): 996.

https://doi.org/10.1182/blood.V114.22.996.996

Published: 2009

Journal Articles

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Marvin M. van Luijn, Martine E.D. Chamuleau, MD, PhD, Maaike E. Ressing, PhD, Emmanuel J.H.J. Wiertz, PhD, Suzanne Ostrand-Rosenberg, PhD, Yuri Souwer, Adri Zevenbergen, Gert J. Ossenkoppele, MD, PhD, Arjan A. van de Loosdrecht, MD, PhD, S. Marieke van Ham, PhD

Blood (2009) 114 (22): 3114.

https://doi.org/10.1182/blood.V114.22.3114.3114

Published: 2009

Journal Articles

Modification of Invariant Chain and CLIP Expression Increases the Immunogenicity of Leukemic Blasts to Potentiate Leukemia-Specific T Cell Reactivity

Marvin M. van Luijn, MSc, Martine E.D. Chamuleau, MD, James A. Thompson, PhD, Suzanne Ostrand-Rosenberg, PhD, Theresia M. Westers, PhD, Yuri Souwer, MSc, Gert J. Ossenkoppele, MD, PhD, S. Marieke van Ham, PhD, Arjan A. van de Loosdrecht, MD, PhD

Blood (2008) 112 (11): 5430.

https://doi.org/10.1182/blood.V112.11.5430.5430

Published: 2008

Journal Articles

TAP- and Proteasome-Dependent Endogenous Antigen Loading of HLA Class II in Leukemic Blasts Introduces a Promising New Target for Generating Leukemia-Specific CD4 + T Cells

Marvin M. van Luijn, MSc, Maaike E. Ressing, PhD, Emmanuel J.H.J. Wiertz, PhD, Adri Zevenbergen, Martine E.D. Chamuleau, MD, Yuri Souwer, MSc, Suzanne Ostrand-Rosenberg, PhD, Gert J. Ossenkoppele, MD, PhD, Arjan A. van de Loosdrecht, MD, PhD, S. Marieke van Ham, PhD

Blood (2008) 112 (11): 5443.

https://doi.org/10.1182/blood.V112.11.5443.5443

Published: 2008

NARROW

Response: priming of human naive CD4 + T cells via CD5 costimulation requires IL-6 for optimal Th17 development

CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation

Low CLIP Expression On Leukemic Blasts From AML Patients Is Essential for the Generation of Effective CD4 + T Cell Responses.

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Modification of Invariant Chain and CLIP Expression Increases the Immunogenicity of Leukemic Blasts to Potentiate Leukemia-Specific T Cell Reactivity

TAP- and Proteasome-Dependent Endogenous Antigen Loading of HLA Class II in Leukemic Blasts Introduces a Promising New Target for Generating Leukemia-Specific CD4 + T Cells

Email alerts

ASH Publications

American Society of Hematology

Response: priming of human naive CD4 + T cells via CD5 costimulation requires IL-6 for optimal Th17 development

CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation

Low CLIP Expression On Leukemic Blasts From AML Patients Is Essential for the Generation of Effective CD4 + T Cell Responses.

Myeloid Leukemic Blasts Use the Endogenous HLA Class I Antigen Processing Machinery for Peptide Loading Onto HLA Class II Molecules: Implications for Immunotherapy.

Modification of Invariant Chain and CLIP Expression Increases the Immunogenicity of Leukemic Blasts to Potentiate Leukemia-Specific T Cell Reactivity

TAP- and Proteasome-Dependent Endogenous Antigen Loading of HLA Class II in Leukemic Blasts Introduces a Promising New Target for Generating Leukemia-Specific CD4 + T Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only